GRIP
Research Group on Infections in Primary Care
The group is made up of family physicians working in different lines of research on infectious diseases in primary care. We have collaborations with Catalan, Spanish and international universities and scientific societies of primary care in Catalonia and abroad. We actively participate in research by independent organizations in Catalonia, Spain and abroad. The primary objective of the group is to promote a more reasoned prescription of antimicrobials in primary care, identifying the subgroups of patients who really need them and avoiding them when they are not necessary. Other objectives are the microbiological aspects of the most prevalent community germs, identifying whether the etiology is bacterial or viral, resistance and prognosis of the most common infections. Another objective is to provide the family physician with diagnostic tools for community infections by means of rapid diagnostic methods.
The group participates in the following projects
|
PI: Moragas Moreno, Ana. Maneig de les ITUS a Catalunya: estudi descriptiu del maneig diagnòstic i terapèutic, i l'impacte de les teràpies supressores en la gravetat d'infeccions potencialment greus [Estudi ITUCAT]. Funding: Departament de Salut. Duration: 2022 - 2024 |
|
PI: Moragas Moreno, Ana. Maneig de les ITUS a Catalunya: estudi descriptiu del maneig diagnòstic i terapèutic, i l'impacte de les teràpies supressores en la gravetat d'infeccions potencialment greus [Estudi ITUCAT]. Funding: Departament de Salut. Duration: 2022 - 2024 |
|
PI: Llor Vilà, Carles. IMproving Antibiotic prescribinG In NursIng homEs in Spain. A before and after intervention study (IMAGINE Study). Funding: Pfizer Inc.. Duration: 2022 - 2024 |
|
PI: Moragas Moreno, Ana. First void OR Midstream Urine sampling among women with Lower urinAry tract infection symptoms.. Funding: ICS - Institut Català de la Salut. Duration: 2022 - 2024 |
|
PI: Llor Vilà, Carles. Improving antibiotic use in long term care facilities by infection prevention and control and antibiotic stewardship. Funding: European Commission. Duration: 2022 - 2024 |
|
PI: Llor Vilà, Carles. Improving antibiotic use in long term care facilities by infection prevention and control and antibiotic stewardship. Funding: European Commission. Duration: 2022 - 2024 |
|
PI: Llor Vilà, Carles. Efectividad clínica y erradicación bacteriológica de 4 pautas antibióticas cortas en infecciones urinarias en mujeres adultas. estudio SCOUT. Funding: Instituto de Salud Carlos III. Duration: 2021 - 2024 |
|
PI: Llor Vilà, Carles. Efectividad clínica y erradicación bacteriológica de 3 pautas antibióticas cortas y monodosis de fosfomicina trometamol en las infecciones urinarias bajas no complicadas en mujeres adultas. Funding: Instituto de Salud Carlos III. Duration: 2021 - 2024 |
|
PI: Llor Vilà, Carles. Community acquired acute respiratory tract infection (CA-ARTI) in community care in Europe: point prevalence audit study (PPAS) of presentation and management. Funding: University of Oxford. Duration: 2019 - 2024 |
|
PI: Llor Vilà, Carles. Health Alliance for Prudent Prescription and Yield of Antibiotics in a Patient-centred Perspective - Happy Patient. Funding: European Commission. Duration: 2021 - 2023 |
|
PI: Llor Vilà, Carles. Health Alliance for Prudent Prescription and Yield of Antibiotics in a Patient-centred Perspective - Happy Patient. Funding: European Commission. Duration: 2021 - 2023 |
|
PI: Llor Vilà, Carles. Platform randomised controlled trial of point of care diagnostics for enhancing the quality of antibiotic prescribing for community acquired acute respiratory tract infection in ambulatory care in Europe (PRUDENCE). Funding: University of Oxford. Duration: 2021 - 2022 |
|
PI: Llor Vilà, Carles. Effectiveness and cost-effectiveness of Improving clinicians' diagnostic and communication Skills on Antibiotic prescribing Appropriateness in patients with acute Cough in primary care in CATalonia. Funding: Fundacio La Marato de TV3. Duration: 2019 - 2022 |
|
PI: Llor Vilà, Carles. Intervention Study - Effectiveness and cost-effectiveness of Improving clinicians' diagnostic and communication Skills on Antibiotic prescribing Appropriateness in patients with acute Cough in primary care in CATalonia.. Funding: ICS - Institut Català de la Salut. Duration: 2019 - 2022 |
|
PI: Llor Vilà, Carles. Efectividad del tratamiento antitusígeno, anticolinérgico y miel versus práctica habitual en adultos con bronquitis aguda no complicada.. Funding: Instituto de Salud Carlos III. Duration: 2018 - 2022 |
The group participates in the following publications
|
Bjerrum A, García-Sangenís A, Modena D, Córdoba G, Bjerrum L, Chalkidou A, Lykkegaard J, Hansen MP, Søndergaard J, Nexøe J, Rebnord I, Sebjørnsen I, Jensen JN, Hansen MB, Taxis K, Lambert M, Benko R, González López-Valcárcel B, Raynal F, Barragán N, Touboul P, Bruno P, Radzeviciene R, Jaruseviciene L, Bandzaite A, Godycki-Cwirko M, Kowalczyk A, Lionis C, Karkana MN, Anastasaki M, Coleman J, Glasová H, van Agtmael M, Tattevin P, Borràs A, Llor C. Health alliance for prudent prescribing and yield of antibiotics in a patient-centred perspective (HAPPY PATIENT): a before-and-after intervention and implementation study protocol. BMC Prim Care. 2022 May; 23(1):102. doi:10.1186/s12875-022-01710-1. Epub 2022 May 02. pmc:PMC9063370. PMID:35501712. IF: . |
|
Gadalla A, Wise H, Farewell D, Hughes K, Llor C, Moore M, Verheij TJ, Little P, Butler CC, Francis NA. Antibiotic consumption and time to recovery from uncomplicated urinary tract infection: secondary analysis of observational data from a point-of-care test trial. Br J Gen Pract. 2022 Dec; 72(725):e882-e890. doi:10.3399/BJGP.2022.0011. Epub 2022 Nov 24. pmc:PMC9678378. PMID:36376070. IF: 5,386. |
|
Gallardo S, Troncoso-Mariño A, Nadal-Braqué N, Amado-Guirado E, Mallecot YH, Llor C; PROA-ICS Barcelona Study Group. Improved management of cystitis in primary care following the implementation of a simple multifaceted intervention. Aten Primaria. 2022 Nov; 54(11):102493. doi:10.1016/j.aprim.2022.102493. Epub 2022 Oct 18. pmc:PMC9586853. PMID:36270205. IF: 1,137. |
|
Gillespie D, Francis N, Ahmed H, Hood K, Llor C, White P, Thomas-Jones E, Stanton H, Sewell B, Phillips R, Naik G, Melbye H, Lowe R, Kirby N, Cochrane A, Bates J, Alam MF, Butler C. Associations with Post-Consultation Health-Status in Primary Care Managed Acute Exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2022 ; 17:383-394. doi:10.2147/COPD.S340710. Epub 2022 Feb 16. pmc:PMC8859472. PMID:35210767. IF: . |
|
Hansen MP, Lykkegaard J, Søndergaard J, Munck A, Llor C. How to improve practice by means of the Audit Project Odense method. Br J Gen Pract. 2022 05; 72(718):235-236. doi:10.3399/bjgp22X719417. Epub 2022 Apr 28. PMID:35483949. IF: 5,386. |
|
Lambert M, Benk? R, Chalkidou A, Lykkegaard J, Hansen MP, Llor C, Touboul P, Tre?iokien? I, Karkana MN, Kowalczyk A, Taxis K. Developing a Tool for Auditing the Quality of Antibiotic Dispensing in Community Pharmacies: A Pilot Study. Antibiotics (Basel). 2022 Nov; 11(11). doi:10.3390/antibiotics11111529. Epub 2022 Nov 01. pmc:PMC9686662. PMID:36358183. IF: 4,639. |
|
Lambert M, Smit CCH, De Vos S, Benko R, Llor C, Paget WJ, Briant K, Pont L, Van Dijk L, Taxis K. A systematic literature review and meta-analysis of community pharmacist-led interventions to optimise the use of antibiotics. Br J Clin Pharmacol. 2022 Feb; doi:10.1111/bcp.15254. Epub 2022 Feb 02. PMID:35112381. IF: 4,335. |
|
Llor C, Cordoba G, de Oliveira SM, Bjerrum L, Moragas A. Antibiotic deprescribing: Spanish general practitioners' views on a new strategy to reduce inappropriate use of antibiotics in primary care. Eur J Gen Pract. 2022 Dec; 28(1):217-223. doi:10.1080/13814788.2022.2130887. pmc:PMC9629099. PMID:36314609. IF: 1,904. |
|
Llor C, Moragas A, Aguilar-Sánchez M, García-Sangenís A, Monfà R, Morros R. Best methods for urine sample collection for diagnostic accuracy in women with urinary tract infection symptoms: a systematic review. Fam Pract. 2022 Jun; doi:10.1093/fampra/cmac058. Epub 2022 Jun 02. PMID:35652481. IF: 2,267. |
|
Llor C, Moragas A, Bjerrum L. Deprescribing in old people: Only for chronic medication?. Aten Primaria. 2022 Sep; 54(9):102427. doi:10.1016/j.aprim.2022.102427. Epub 2022 Jul 15. pmc:PMC9293734. PMID:35850083. IF: 1,137. |
|
Llor C, Moragas A, Cots JM. Implementation of the delayed antibiotic prescribing strategy. Prospective observation study in primary care. Rev Esp Quimioter. 2022 Apr; 35(2):213-217. doi:10.37201/req/141.2021. Epub 2022 Feb 03. pmc:PMC8972696. PMID:35109645. IF: 1,553. |
|
Llor C, Moragas A, Miravitlles M, Mesquita P, Cordoba G. Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis. Pulm Pharmacol Ther. 2022 02; 72:102111. doi:10.1016/j.pupt.2022.102111. Epub 2022 Jan 13. PMID:35032637. IF: 3,410. |
|
Llor C, Moragas A, Ouchi D, Monfà R, Garcia-Sangenís A, Gómez-Lumbreras A, Pera H, Pujol J, Morros R. Effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with uncomplicated acute bronchitis: a multiarm randomized clinical trial. Fam Pract. 2022 Oct; doi:10.1093/fampra/cmac112. Epub 2022 Oct 14. pmc:PMC9619792. PMID:36239199. IF: 2,267. |
|
Llor C. Antibiotics Use in Primary Care during COVID-19. Antibiotics (Basel). 2022 May; 11(6). doi:10.3390/antibiotics11060744. Epub 2022 May 31. pmc:PMC9219702. PMID:35740151. IF: 4,639. |
|
Verheij TJ, Cianci D, van der Velden AW, Butler CC, Bongard E, Coenen S, Colliers A, Francis NA, Little P, Godycki-Cwirko M, Llor C, Chlabicz S, Lionis C, Sundvall PD, Bjerrum L, De Sutter A, Aabenhus R, Harbin NJ, Lindbæk M, Glinz D, Bucher HC, Kovács B, Seifert B, Jurgute RR, Lundgren PT, de Paor M, Matheeussen V, Goossens H, Ieven M. Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data. Br J Gen Pract. 2022 03; 72(716):e217-e224. doi:10.3399/BJGP.2021.0344. Epub 2022 Feb 24. pmc:PMC8803087. PMID:34990385. IF: 5,386. |
|
Waldorff MS, Bjerrum L, Holm A, Siersma V, Bang C, Llor C, Cordoba G. Influence of Antimicrobial Resistance on the Course of Symptoms in Female Patients Treated for Uncomplicated Cystitis Caused by . Antibiotics (Basel). 2022 Jan; 11(2). doi:10.3390/antibiotics11020188. Epub 2022 Jan 31. pmc:PMC8868151. PMID:35203790. IF: 4,639. |
Indicators
|
Indicator |
2022 |
|---|---|
|
Researchers with PhD |
10 |
|
Total number of projects in which group members have participated |
16 |
|
Total number of projects in which the PI of the project has belonged to the group |
16 |
|
Total Funding |
1.655.845,16€ |
|
Scientific publications in indexed journals |
14 |
|
Total Impact factor |
48,09 |
|
Nº of articles in Q1 journals |
3 |
|
Q1 IF |
16,158 |
|
Nº of articles in Q2 journals |
5 |
|
Q2 IF |
21,662 |
